23115068

Szydlarska D

2012

Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?

23116196

Rey-Roldan E

2013

Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?

23118426

Mutharasan P

2013

Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry.

23118428

Huang ZH

2013

PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity.

23119079

Marino JS

2012

Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.

23120786

Vlasov PN

2011

[Peculiarities of epilepsy in women with menstrual dysfunction].

23122578

Maliqueo M

2013

Placental steroidogenesis in pregnant women with polycystic ovary syndrome.

23122827

Azziz R

2013

Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome.

23122829

Sova H

2013

Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome.

23124626

Mohsen IA

2013

Effect of metformin treatment on endometrial vascular indices in anovulatory obese/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography.

23127112

Yildir IC

2013

Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test.

23127146

Fanta M

2013

Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?

23127604

Rellini AH

2013

Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome.

23132696

Lavery GG

2013

Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling.

23141287

Wang LL

2012

[Therapeutic effect of metformin for clomiphene-resistant infertility patients with polycystic ovary syndrome: a systematic analysis].

23141431

Lee MS

2012

Metformin enhances the action of insulin on porcine granulosa-lutein cells in vitro.

23148145

Sathyapalan T

2010

Evidence for statin therapy in polycystic ovary syndrome.

23148156

Lashen H

2010

Role of metformin in the management of polycystic ovary syndrome.

23148188

Pangaribuan B

2011

Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.

23148192

Bargiota A

2012

The effects of old, new and emerging medicines on metabolic aberrations in PCOS.

23148203

Capalbo A

2013

Sequential comprehensive chromosome analysis on polar bodies, blastomeres and trophoblast: insights into female meiotic errors and chromosomal segregation in the preimplantation window of embryo development.

23155436

Wickenheisser JK

2012

Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome.

23156258

Jobo T

2012

[Natural history and risk factors of endometrial carcinoma].

23157045

Rodrigues-Junior DM

2012

Effects of tamoxifen and raloxifene on body and uterine weights of rats in persistent estrus.

23158559

Xie M

2012

[Ovarian ultrasonographic features in reproductive age females with polycystic ovary syndrome and the establishment of ultrasonographic criteria].

23158749

Kale-Gurbuz T

2013

Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome.

23158931

Gonz?lez F

2013

Adrenal dysfunction in polycystic ovary syndrome: has it been lost to follow-up?

23158933

Moro F

2013

Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis.

23158978

Patra SK

2012

Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome.

23159022

Gugatschka M

2013

Subjective and objective vocal parameters in women with polycystic ovary syndrome.

23162354

Kumar P

2012

Effects of metformin use in pregnant patients with polycystic ovary syndrome.

23162945

Stender SR

2012

A hairy situation.

23163158

Wang XJ

2012

[The Chinese medicine syndrome typing mode at the same level is the key point to explore the syndrome laws of disease. An inspiration from studying Chinese medicine syndrome laws of polycystic ovarian syndrome].

23163164

Zheng YH

2012

[Treatment of PCOS by acupuncture: present experimental and clinical reports].

23163753

Hilali N

2013

Increased prolidase activity and oxidative stress in PCOS.

23173761

Gabrielli L

2012

Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare.

23174031

Teng HW

2013

The relationship between carotid intima-media thickness and endogenous androgens in young women with polycystic ovary syndrome in Taiwan.

23176069

Chang EM

2013

Insulin resistance does not affect early embryo development but lowers implantation rate in in vitro maturation-in vitro fertilization-embryo transfer cycle.

23177353

Mahmood K

2013

Metformin: the hidden chronicles of a magic drug.

23177415

Kim MK

2013

Does supplementation of in-vitro culture medium with melatonin improve IVF outcome in PCOS?

23182554

McLean M

2012

Optimizing natural fertility: the role of lifestyle modification.

23182556

Bates GW Jr

2012

Polycystic ovarian syndrome management options.

23182557

Propst AM

2012

Evaluation and treatment of anovulatory and unexplained infertility.

23182796

Lin LH

2013

Androgen receptor gene polymorphism and polycystic ovary syndrome.

23183180

Maliqueo M

2013

Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age.

23185203

Cicero AF

2012

Metformin and its clinical use: new insights for an old drug in clinical practice.

23185989

Yaba A

2012

The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS).

23188113

Ikeda K

2013

Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology.

23190271

Homburg R

2012

The re-growth of growth hormone in fertility treatment: a critical review.

23191935

Moreno JL

2012

Exenatide as a novel weight loss modality in patients without diabetes.

23194004

Nascimento AD

2013

Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.

23194076

Vosnakis C

2013

Diet, physical exercise and Orlistat administration increase serum anti-M?llerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

23194095

Xiao J

2013

Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis.

23194199

Palomba S

2013

Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials.

23197113

Mayama R

2013

Improvement of insulin sensitivity promotes extravillous trophoblast cell migration stimulated by insulin-like growth factor-I.

23198915

Zhao Y

2012

Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.

23199261

Olszanecka-Glinianowicz M

2013

Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances.

23199540

Singh S

2012

Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.

23199811

Salah RM

2013

Bacterial vaginosis and infertility: cause or association?

23200688

Mumm H

2013

Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973-1991.

23200689

Boutzios G

2013

Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring.

23205605

Glueck CJ

2013

Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome.

23206979

Cakir E

2013

Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism.

23208300

Cui L

2013

Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women.

23208318

Vilmann LS

2012

Development of obesity and polycystic ovary syndrome in adolescents.

23209115

Bird ST

2013

Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis.

23210095

Boyle J

2012

Polycystic ovary syndrome - an update.

23210985

Ferraresi SR

2013

Changes in sexual function among women with polycystic ovary syndrome: a pilot study.

23211375

Hoirisch-Clapauch S

2013

Psychiatric remission with warfarin: Should psychosis be addressed as plasminogen activator imbalance?

23211475

Glintborg D

2013

Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.

23211631

Vaggopoulos V

2013

Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.

23216335

Koiou E

2013

Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome.

23216997

Cinar N

2012

Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome.

23218173

Lerchbaum E

2013

Hypertriglyceridemic waist is associated with impaired glucose tolerance in polycystic ovary syndrome.

23218400

Rashad NM

2013

Association between inflammatory biomarker serum procalcitonin and obesity in women with polycystic ovary syndrome.

23219008

Tannus S

2013

The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on?in?vitro fertilization outcome.

23221034

Karaca Z

2013

Routine screening for Cushing's syndrome is not required in patients presenting with hirsutism.

23225242

Ormazabal P

2013

Decreased phosphorylation of Y??caveolin-1 in endometrial tissue of polycystic ovary syndrome patients may be related with an insulin resistant state in this tissue.

23225249

Whiting L

2013

D-chiro-inositol attenuates epinephrine-stimulated hepatic glucose output in the isolated perfused liver independently of insulin.

23226075

Baba T

2012

Weight reduction and pioglitazone ameliorate polycystic ovary syndrome after removal of a Sertoli-stromal cell tumor.

23226647

Nisar S

2012

Association of polycystic ovary syndrome and Graves' disease: Is autoimmunity the link between the two diseases.

23226650

Saxena P

2012

Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index.

23226652

Karoli R

2012

Study of early atherosclerotic markers in women with polycystic ovary syndrome.

23226656

Shamim N

2012

The elasticity of cervical-vaginal secretions is abnormal in polycystic ovary syndrome: Case report of five PCOS women.

23226817

Al Kindi MK

2012

Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism.

23231038

Singh IP

2013

Berberine and its derivatives: a patent review (2009 - 2012).

23232534

Carmina E

2012

PCOS: metabolic impact and long-term management.

23232537

De Leo V

2012

[Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients].

23232975

Deepika ML

2013

Do ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS?

23235401

Seow KM

2013

Aquaglyceroporin-7 overexpression in women with the polycystic ovary syndrome.

23237575

Roessler KK

2013

Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.

23240945

Bates GW

2013

Physiology of the female reproductive axis.

23243014

Khalaf M

2013

BMP system expression in GCs from polycystic ovary syndrome women and the in vitro effects of BMP4, BMP6, and BMP7 on GC steroidogenesis.

23246977

Zadeh-Vakili A

2013

Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS.

23249394

Gonen T

2013

Tear osmolarity and ocular surface changes in patient with polycystic ovary syndrome.

23249450

Cakir E

2012

Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients.

23249695

Gonz?lez F

2013

Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.

23254197

Moore AM

2013

Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome.

23256828

Petr?kov? J

2012

[Is polycystic ovary syndrome associated with autoimmune thyroiditis?].

23257395

Sasidevi A

2013

Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome.